Leukemia
Conditions
Interventions
This is a randomized, single-blind, clinical trial: will be allocated 60 children will be allocated into 2 groups: Group I (Intervention) and Group C (Control), composed of 30 participants each, who m
G11.427.410.698.277
Sponsors
Centro Universitário Faculdade de Medicina do ABC
Centro Universitário Faculdade de Medicina do ABC
Eligibility
Age
8 Years to 17 Years
Inclusion criteria
Inclusion criteria: Individuals between 8 and 17 years old; with diagnosed oncohematological disease; hospitalized in a pediatric ward; both sexes; clinically compensated participants with respiratory, cardiac or musculoskeletal pathologies prior to cancer diagnosis; that they accept to participate in the research and those responsible sign the informed consent form and that the participant signs the informed consent form
Exclusion criteria
Exclusion criteria: Participants with cognitive alterations that make the assessment impossible; participants who present one or more of the following criteria: body temperature > 38ºC, pain with a visual analogue pain scale of 5 or above, constant diarrhea, uncontrolled bleeding, tachycardia and/or hypotension (mean arterial pressure - MAP less than 60); participants with blood count alterations less than 8.0mg/dl and symptoms of decompensation and platelets less than 20.000/mm3
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to determine improvement in the functional capacity of pediatric oncohematologic patients with an exercise program during hospital stay. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to determine improvement in fatigue, quality of life and pain of pediatric oncohematologic patients with an exercise program during hospital stay. | — |
Countries
Brazil
Contacts
Public ContactCintia Freire Carniel
Centro Universitário Faculdade de Medicina do ABC
Outcome results
None listed